4D pharma (LBPSW) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock LBPSW vs. ATNFW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying 4D pharma stock or one of its competitors? The main competitors of 4D pharma include 180 Life Sciences (ATNFW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. 4D pharma vs. 180 Life Sciences Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate 4D pharma (NASDAQ:LBPSW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations. Does the media prefer LBPSW or ATNFW? In the previous week, 180 Life Sciences had 2 more articles in the media than 4D pharma. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for 4D pharma. 180 Life Sciences' average media sentiment score of 1.24 beat 4D pharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment 4D pharma Neutral 180 Life Sciences Positive Does the MarketBeat Community believe in LBPSW or ATNFW? 4D pharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform4D pharmaN/AN/A180 Life SciencesN/AN/A Which has stronger earnings & valuation, LBPSW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio4D pharma$522KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is LBPSW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets 4D pharmaN/A N/A N/A 180 Life Sciences N/A N/A N/A Summary180 Life Sciences beats 4D pharma on 2 of the 3 factors compared between the two stocks. Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPSW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LBPSW vs. The Competition Export to ExcelMetric4D pharmaPharmaceutical Preparation Manufacturing IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/AN/A$2.03B$7.97BDividend YieldN/AN/A2.70%4.23%P/E RatioN/AN/A22.4718.58Price / SalesN/AN/A60.21103.15Price / CashN/AN/A51.7234.62Price / BookN/AN/A1.994.26Net IncomeN/AN/A-$333.48M$248.31M 4D pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AATNFW180 Life SciencesN/A$0.01flatN/A-11.8%$0.00N/A0.007News CoveragePositive NewsGap DownAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002AIMDWAinosN/A$0.10-5.9%N/AN/A$0.00$20,729.000.0040Positive NewsALVOWAlvotechN/A$1.32+3.1%N/A-59.3%$0.00$489.68M0.004Short Interest ↑News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02-20.5%N/A-76.3%$0.00N/A0.0015BFRIWBiofronteraN/A$0.04-13.1%N/AN/A$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.02-5.1%N/A-89.9%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12+8.0%N/A-86.8%$0.00N/A0.008Gap UpCELUWCelularityN/A$0.04-10.1%N/A+14.0%$0.00$48.20M0.00220Positive NewsCINGWCingulateN/A$0.04+10.5%N/A+90.9%$0.00N/A0.0020Gap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LBPSW) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.